David Peereboom

9PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Mining, energy and natural resources lawCancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 22, 2026
Phase 2 study of regorafenib in patients with progressive glioblastoma after failure of bevacizumab.

|Mar 12, 2026
Racial Disparities in Glioblastoma: Can We Untangle Biological From Nonbiological Forces?

David M Peereboom

|Jan 23, 2026
Role of Immunotherapy and Targeted Agents to Treat Brain Metastases.

Nicole Hajdari, David M Peereboom

|Dec 01, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Howard Colman, Giuseppe Lombardi, Eric T Wong

|Jan 17, 2025
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma.

Eudocia Q Lee, Brian M Alexander, Carlos G Romo

|Jun 21, 2024
Breast Cancer Brain Metastases: Challenges and Opportunities.

David M Peereboom

Pageof 2

Frequent Collaborators

4 joint publications

Manmeet S Ahluwalia

3 joint publications

Louis B Nabors

3 joint publications

Patrick Y Wen

2 joint publications

William T Curry